• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-BCCIP

BCCIP Polyclonal Antibody for WB, IF/ICC, IP, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IF/ICC, IP, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 16043-1-PBS

Synonymes

TOK1, TOK 1, Protein TOK-1, Protein TOK 1, P21- and CDK-associated protein 1



Informations sur le produit

16043-1-PBS cible BCCIP dans les applications de WB, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène BCCIP Protéine recombinante Ag8934
Nom complet BRCA2 and CDKN1A interacting protein
Masse moléculaire calculée 314 aa, 36 kDa
Poids moléculaire observé 50-58 kDa
Numéro d’acquisition GenBankBC009771
Symbole du gène BCCIP
Identification du gène (NCBI) 56647
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

BCCIP (or TOK1) is isolated as a BRCA2- and CDKN1A (p21)-interacting protein and is implicated in homologous recombination (HR) pathway and inhibition of DNA replication stress. BCCIP is an evolutionarily conserved nuclear protein with multiple interacting domains. BCCIP deficiency in mice impaired embryonic and postnatal neural development, causing severe ataxia, cerebral and cerebellar defects, and microcephaly, which are associated with spontaneous DNA damage and subsequent cell death in the proliferative cell populations of the neural system during embryogenesis. BCCIP is essential for maintaining the transactivation activity of wild type p53 suggesting a potential role of BCCIP in cancer etiology.

{{ptg:RelatedPrimaryAntibodies}}